Emily Letton | News Reporter

Articles and archive:

Analysis | Cell & Gene Therapy | Design & Build | Digital | Distribution | Drug Delivery | Finance | Finished Product | Hi Tech Manufacturing | Ingredients | Logistics | Manufacturing | Marketing | Media | Microbiology | Packaging | Pharma 5.0 | Pharmaceutical | Regulatory | Research & Development | Sustainability

Emily covers the ever-changing pharma landscape and innovative ingredients from the supplement sector, with particular interest in sports nutrition and the policies and regulations shaping the market

Emily Letton

Profile

Emily is the Scientific Reporter for Nutraceutical Business Review and Manufacturing Chemist. Emily has a background in Biomedical Science and Genetics and a Master’s degree in Journalism from Oxford Brookes University. When she’s not reporting on the latest news, you'll find her in a boat on the river.

 

Related content

Cell & Gene Therapy
Northway Biotech opens €61m cell therapy CDMO in Lithuania

Northway Biotech opens €61m cell therapy CDMO in Lithuania

The new 3500 sq m Vilnius facility will provide up to 20 independent cGMP manufacturing lines for cell therapies and personalised medicines
Manufacturing
PerkinElmer acquires SimoTech to expand pharma manufacturing automation

PerkinElmer acquires SimoTech to expand pharma manufacturing automation

The acquisition strengthens PerkinElmer’s pharmaceutical services offering with SimoTech’s expertise in manufacturing automation, digital manufacturing and GMP IT systems
Manufacturing
FDA warns Fresenius over leaking sterile drug bags and GMP failures

FDA warns Fresenius over leaking sterile drug bags and GMP failures

FDA has cited significant cGMP violations at Fresenius Medical Care’s Ogden, Utah, manufacturing facility, including recurring leaking dialysis solution bags and inadequate quality investigations
Manufacturing
Waterfall Scientific heads $54.5m ARPA-H consortium to build continuous-flow mRNA manufacturing platform

Waterfall Scientific heads $54.5m ARPA-H consortium to build continuous-flow mRNA manufacturing platform

The ESCALATOR project integrates enzymatic DNA synthesis, LNP formulation, microfluidics and automated analytics into an end-to-end system — aiming to reduce production lead time from weeks to days for personalised oncology and pandemic response
Manufacturing
NewBiologix and Synastra Biotechnology partner for stable rAAV manufacturing in DMD gene therapy

NewBiologix and Synastra Biotechnology partner for stable rAAV manufacturing in DMD gene therapy

The pair will use NewBiologix's Xcell platform to establish a stable producer cell line to scale manufacturing for Synastra’s investigational DMD gene therapy programme
Finance
Novartis signs up to $3.2bn Alteogen deal for subcutaneous drug delivery

Novartis signs up to $3.2bn Alteogen deal for subcutaneous drug delivery

The agreement gives Novartis options to develop and commercialise multiple subcutaneous products using Alteogen’s ALT-B4 hyaluronidase technology
Manufacturing
Syntegon opens new OSD Customer Center in Germany

Syntegon opens new OSD Customer Center in Germany

The firm has opened a 7900 sqm OSD Customer Centre in Fellbach, Germany, featuring cleanrooms, a powder laboratory and tablet and capsule equipment to support pharmaceutical and nutraceutical formulation and manufacturing development
Media
CPHI Milan Pharma Awards finalists revealed for 2026

CPHI Milan Pharma Awards finalists revealed for 2026

This year's finalists for the CPHI Pharma Awards have been decided from hundreds of entries received across 15 categories, showcasing companies, technologies and individuals making an impact in pharma
Finance
Lilly to acquire Merida Biosciences for up to $2.875bn

Lilly to acquire Merida Biosciences for up to $2.875bn

Eli Lilly is acquiring Merida Biosciences in a deal worth up to $2.875bn to expand its pipeline of precision therapies for autoimmune and allergic diseases
Logistics
Systech launches AI-powered traceability platform for pharma supply chains

Systech launches AI-powered traceability platform for pharma supply chains

Systech International has launched TraceIQ, a new traceability platform combining pharmaceutical compliance capabilities with AI-assisted analytics to help manufacturers prevent disruptions and improve operational decision-making
Research & Development
Jocasta expands UCSF α-klotho licence ahead of 2027 Phase I trial

Jocasta expands UCSF α-klotho licence ahead of 2027 Phase I trial

Jocasta Neuroscience has secured expanded exclusive rights to UCSF α-klotho intellectual property as it advances JN-0413 towards first-in-human testing for cognitive impairment and neurodegenerative disease
Packaging
OPTIMA expands sustainability drive across machinery portfolio

OPTIMA expands sustainability drive across machinery portfolio

OPTIMA has published its second CSRD-aligned sustainability report, highlighting progress on renewable energy, emissions management, energy-efficient machinery and information security